Leadership Overview
Cipla has 8 executives leading key functions including digital health, North American operations, financial management, information technology, revenue generation, marketing operations, commercial excellence, and human resources.
Committed to advancing global healthcare access, Cipla delivers high-quality generic and branded medicines across diverse therapeutic areas to improve patient outcomes worldwide.
Committed to advancing global healthcare access, Cipla delivers high-quality generic and branded medicines across diverse therapeutic areas to improve patient outcomes worldwide.
Leadership Roles at Cipla
Ashish Vig - Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies)
Ashish Vig, the Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies) at Cipla, directs the expansion of digital health initiatives and modern retail channels. Vig architects strategies to integrate eCommerce platforms with organized retail pharmacies, ensuring seamless access to essential medications. By leveraging digital transformation, the Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies) optimizes consumer engagement across diverse markets. Ashish Vig drives the adoption of innovative health solutions, bridging the gap between traditional pharmaceutical distribution and modern consumer needs. This leadership role focuses on scaling digital infrastructure to support the broader mission of providing affordable healthcare. Through meticulous oversight of retail partnerships, the Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies) enhances market penetration and strengthens the company's position in the rapidly evolving digital health landscape.
Marc Falkin - Chief Executive Officer (North America)
Marc Falkin, the Chief Executive Officer (North America) at Cipla, manages all pharmaceutical operations and strategic growth initiatives across the North American market. Falkin oversees the distribution of generic and branded medicines, ensuring compliance with regional regulatory standards while maximizing market share. The Chief Executive Officer (North America) coordinates with global leadership to align regional objectives with the overarching corporate mission of delivering high-quality healthcare solutions. By identifying emerging opportunities in the North American pharmaceutical sector, Marc Falkin drives revenue growth and operational efficiency. This role involves managing complex supply chains and fostering relationships with key healthcare stakeholders to maintain a competitive edge. Through rigorous market analysis and strategic planning, the Chief Executive Officer (North America) secures the company's footprint in the region, consistently delivering value to patients and partners while navigating the intricacies of the North American healthcare environment.
Lynette Biddulph - Chief Financial Officer
Lynette Biddulph, the Chief Financial Officer at Cipla, directs the global financial strategy, capital allocation, and fiscal reporting processes. Biddulph oversees the management of financial risks and ensures the integrity of all accounting operations across international markets. The Chief Financial Officer maintains alignment between fiscal performance and the company's long-term growth objectives in the pharmaceutical sector. By optimizing capital structures and monitoring investment returns, Lynette Biddulph supports the development of new ventures and the expansion of the core product portfolio. This leadership role involves close collaboration with the Board to provide transparent financial insights and drive sustainable profitability. Through disciplined financial oversight, the Chief Financial Officer strengthens the company's balance sheet, enabling continued investment in research, manufacturing, and global distribution networks. Biddulph ensures that financial resources effectively support the delivery of essential medicines to patients worldwide.
Vishrut Awasthi - Commercial Excellence Lead - Global Chief Operating Officer Office
Vishrut Awasthi, the Commercial Excellence Lead - Global Chief Operating Officer Office at Cipla, directs initiatives to optimize commercial processes and operational efficiency across the global organization. Awasthi oversees the implementation of best practices in sales force effectiveness, performance management, and market access strategies. The Commercial Excellence Lead - Global Chief Operating Officer Office architects frameworks that align commercial activities with the broader operational goals of the company. By analyzing performance metrics and identifying areas for improvement, Vishrut Awasthi drives continuous enhancement in how the company brings its pharmaceutical products to market. This leadership role involves close coordination with the Chief Operating Officer to ensure that commercial strategies are executed with precision and agility. Through the application of data-driven insights, the Commercial Excellence Lead - Global Chief Operating Officer Office supports the company's growth objectives and ensures that operational resources are utilized to maximize impact in the global healthcare sector.
Sneha Hiranandani - Chief Information Officer
Sneha Hiranandani, the Chief Information Officer at Cipla, architects the global technology roadmap and digital infrastructure necessary for pharmaceutical manufacturing and distribution. Hiranandani oversees cybersecurity, data analytics, and enterprise resource planning systems to ensure operational continuity across all international markets. The Chief Information Officer drives the integration of advanced technologies to streamline supply chain logistics and enhance research capabilities. By implementing robust IT frameworks, Sneha Hiranandani supports the company's commitment to innovation and operational excellence. This leadership role involves managing complex digital transformations that enable real-time decision-making and improved patient care outcomes. Through the strategic deployment of technology, the Chief Information Officer ensures that data-driven insights inform every aspect of the business, from drug development to market delivery. Hiranandani maintains a secure and scalable digital environment that empowers the organization to meet the evolving demands of the global healthcare industry.
Kanchan Israni - Chief Revenue Officer, Category Lead Outsourcing
Kanchan Israni, the Chief Revenue Officer, Category Lead Outsourcing at Cipla, directs revenue growth strategies and manages outsourcing partnerships for key product categories. Israni oversees the commercial performance of diverse therapeutic portfolios, ensuring that market demand is met through efficient supply chain and distribution models. The Chief Revenue Officer, Category Lead Outsourcing architects collaborative frameworks with external partners to optimize manufacturing and logistics, thereby enhancing product availability. By focusing on category-specific growth, Kanchan Israni drives profitability and market expansion across international regions. This leadership role involves aligning revenue targets with operational capabilities to support the company's broad range of medicines. Through strategic management of outsourcing initiatives, the Chief Revenue Officer, Category Lead Outsourcing ensures that the organization maintains a competitive advantage in the pharmaceutical market. Israni consistently delivers results by balancing cost-efficiency with the high-quality standards required for global healthcare delivery.
Rohidas Patil - Sr. Executive Chief Marketing Officer Operations At Cipla
Rohidas Patil, the Sr. Executive Chief Marketing Officer Operations At Cipla at Cipla, directs the execution of global marketing campaigns and brand positioning strategies. Patil oversees the operational aspects of marketing, ensuring that promotional activities effectively communicate the value of the company's pharmaceutical products to healthcare providers and patients. The Sr. Executive Chief Marketing Officer Operations At Cipla architects integrated marketing plans that support the launch of new medicines and the growth of existing therapeutic lines. By analyzing market trends and consumer behavior, Rohidas Patil drives brand awareness and strengthens the company's market presence. This leadership role involves coordinating with cross-functional teams to ensure consistent messaging and high-impact outreach. Through the strategic management of marketing operations, the Sr. Executive Chief Marketing Officer Operations At Cipla enhances the visibility of the company's diverse portfolio, ultimately supporting the mission to provide accessible healthcare solutions on a global scale.
Prabir Jha - Chief People Officer
Prabir Jha, the Chief People Officer at Cipla, directs the global human resources strategy, talent acquisition, and organizational development initiatives. Jha oversees the cultivation of a high-performance culture that supports the company's mission of delivering quality healthcare. The Chief People Officer architects programs for leadership development, employee engagement, and performance management to ensure the organization attracts and retains top talent. By fostering an inclusive and innovative work environment, Prabir Jha drives the professional growth of the workforce across international operations. This leadership role involves aligning human capital strategies with the company's business objectives to support long-term success. Through the strategic management of people-related processes, the Chief People Officer ensures that the organization remains agile and capable of meeting the complex demands of the pharmaceutical industry. Jha empowers employees to contribute effectively to the company's goal of improving patient health outcomes through dedicated and skilled professional efforts.
Explore Leadership Teams in Manufacturing
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Company Leadership

NA
MK
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership TS



PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The companys lead product is Translarna (ataluren), for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. The company is headquartered in South Plainfield, New Jersey.
Company Leadership DM

QN
Sandoz Group AG (SIX: SDZ) is a global healthcare company focused on developing, manufacturing, and delivering high-quality generic medicines and biosimilars. Serving patients worldwide, Sandoz provides treatments across multiple therapeutic areas, including oncology, immunology, and cardiovascular health.
Company Leadership SS
MF
BP
EM